Development of the first-in-human trial for nebulisation of FLAMOD - Vienna 2024

Flagellin aerosol therapy as an immunomodulatory adjunct to the antibiotic treatment of drug-resistant bacterial pneumonia

Chair(s): Andrea Gramegna, Eva Polverino, B?lent Taner Karadag

Session type: Symposium

Development of the first-in-human trial for nebulisation of FLAMOD

Antoine GUILLON

EVENTS HOME

Replay

Previous presentation

Next presentation

Session content

Exploring the immunostimulatory potential of FLAMOD as an adjunct of antibiotics in bacterial pneumonia

Jean-claude Sirard

Replay

Inhalation of FLAMOD: formulation for nebulisation and preclinical evaluation

Nathalie Heuz?-vourc'h

Replay

Development of the first-in-human trial for nebulisation of FLAMOD

Antoine Guillon

Replay

Prognostic and predictive enrichment strategies for immunomodulatory therapies like FLAMOD

Erik Michels

Replay

Discussion and Q&A

Replay

Session aims

To present the progression of the Horizon 2020 European Union project FAIR, tracing its trajectory from preclinical investigations to translational development.

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}